Larvol Delta - 23andMe-Announces-Updated-Safety-and-Preliminary-Efcacy-Data-From-the-Phase-12a-Study-of-23ME00610-an-Investigational-Antibody-Targeting-CD200R1

23ME-00610 - 23andMe

https://www.globenewswire.com/news-release/2023/11/06/2774033/0/en/23andMe-Announces-Updated-Safety-and-Preliminary-Efficacy-Data-From-the-Phase-1-2a-Study-of-23ME-00610-an-Investigational-Antibody-Targeting-CD200R1.html

Nov 6, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next